Physician profile
Angel N Boev
NPI 1083625008
$197,460.60
in general payments reported to CMS, 2019-2025
30 companies · $65K in 2025
The $65K reported for 2025 was more than what 96% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,942 · 2020: $16K · 2021: $7,841 · 2022: $1,257 · 2023: $41K · 2024: $61K · 2025: $65K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $130K · Education: $14K · Food and Beverage: $11K · Travel and Lodging: $6,711 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,245 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,145 · Entertainment: $8.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $130,042.50 |
| Education | $13,671.00 |
| Food and Beverage | $10,551.93 |
| Travel and Lodging | $6,711.28 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,245.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,145.00 |
| Entertainment | $8.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aurora Spine, INC. | $150,000.00 | 2019-2025 | Discovery Tinano Acif |
| Abbott Laboratories | $21,118.33 | 2019-2025 | Proclaim, Eterna |
| Baxter Healthcare | $14,641.38 | 2022-2025 | Tisseel, Floseal, Ostene |
| Boston Scientific Corporation | $4,870.54 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Medtronic, INC. | $2,009.39 | 2021-2024 | Intellis Adaptivestim |
| Nevro Corp. | $1,736.03 | 2019-2023 | Senza |
| Si-Bone, INC. | $1,127.98 | 2022-2024 | |
| Vb Spine LLC | $656.23 | 2025 | Avs Anchor-C, Prolift |
| Spinal Simplicity, LLC | $247.46 | 2022 | |
| Foundation Fusion Solutions, LLC | $174.77 | 2024 | |
| Sanara Medtech INC. | $144.46 | 2021 | |
| Pfizer INC. | $96.97 | 2020-2022 | |
| Ethicon US, LLC | $87.67 | 2025 | Vistaseal, Dermabond Prineo |
| Depuy Synthes Sales INC. | $80.21 | 2023 | Na |
| Spr Therapeutics, INC | $77.52 | 2023-2024 | Sprint Pns System |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $42.55 | 2024-2025 | Spinal-Stim |
| Avanir Pharmaceuticals, INC. | $40.77 | 2021-2022 | |
| Stimwave Technologies Incorporated | $35.86 | 2022 | |
| Intrinsic Therapeutics | $30.37 | 2023 | Barricaid Acd (Annular Closure Device) |
| Arbor Pharmaceuticals, INC. | $29.48 | 2022 | |
| Scilex Pharmaceuticals INC. | $27.58 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $27.06 | 2021 | |
| Kls-Martin L.P. | $26.02 | 2023 | |
| Lemaitre Vascular, INC. | $23.70 | 2022 | |
| Smith+Nephew, INC. | $23.29 | 2023 | Renasys Go V2 Home, Pico |
| Azurity Pharmaceuticals, INC. | $20.67 | 2023 | Nymalize |
| Axogen | $20.04 | 2023 | Avance Nerve Graft |
| Bioventus LLC | $17.36 | 2025 | Bonescalpel & Sonicone (O.R.) |
| Neuronetics, INC. | $13.78 | 2022 | |
| Medtronic USA, INC. | $13.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angel Boev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.